1Cell.Ai

Private

MumbaiHealthcare & Life Scienceshttps://1cell.ai/

Last Round

Series A

Nov 21, 2024

Total Funding Raised

$16.08M

Company Overview

1Cell.Ai is a biotechnology company that provides an AI-powered precision oncology platform designed to accelerate the discovery of rare cell populations and improve cancer diagnostics and treatment.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical AI, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision oncologysingle-cell multi-omicscancer diagnosticsliquid biopsycirculating tumor DNActDNAcirculating tumor cellsCTCsclinical trial recruitmentpatient stratificationlab-developed testsLDTbioinformaticsclinical decision supportmulti-omicsspatial biologybiotech AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

1Cell.Ai Comparables

Compare 1Cell.Ai with similar companies based on industry and business-model similarity.

1Cell.Ai comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

1Cell.Ai Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Nov 21, 2024
Grant	Jul 11, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Mohan Uttarwar

Cofounder CEO

Founding Team

Srikanth Nandiraju

Chief Technology Officer

Executive Team

Avi Nahar

Chief Operating Officer

Executive Team

Aravindan Vasudevan

Chief Product Officer

Executive Team

View all key people

1Cell.Ai Investors

Notable investors and investment history

1Cell.Ai investors
Investor	Rounds
Biotechnology Industry Research Assistance Council	Grant
WRVI Capital	Series A
Eragon Ventures	Series A
Singularity Growth	Series A
Department of Biotechnology	Grant
Tenacity Ventures	Series A

View all Investors

1Cell.Ai Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

1Cell.Ai Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 1Cell.Ai's valuation, stock price, and market status.

Firmographic Details

HeadquartersMumbai

Employee Range196

Year Founded2021

Last FundingNov 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.